Literature DB >> 8563612

Increasing prescription of drugs for secondary prevention of myocardial infarction. Authors' recommendations are too restrictive.

R J Sapsford, M B Robinson, A S Hall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8563612      PMCID： PMC2350041          DOI： 10.1136/bmj.312.7025.252a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  The Acute Infarction Ramipril Efficacy (AIRE) Study: rationale, design, organization, and outcome definitions.

Authors:  A S Hall; C Winter; S M Bogle; A F Mackintosh; G D Murray; S G Ball
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

2.  Increasing prescription of drugs for secondary prevention after myocardial infarction.

Authors:  J Smith; K S Channer
Journal:  BMJ       Date:  1995-10-07

3.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

Authors:  L Køber; C Torp-Pedersen; J E Carlsen; H Bagger; P Eliasen; K Lyngborg; J Videbaek; D S Cole; L Auclert; N C Pauly
Journal:  N Engl J Med       Date:  1995-12-21       Impact factor: 91.245
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.